Fenofibrate, a PPARα agonist, has renoprotective effects in mice by enhancing renal lipolysis-Reference-Cited by-同舟云学术

Fenofibrate, a PPARα agonist, has renoprotective effects in mice by enhancing renal lipolysis

Published:2011-04 Issue:8 Volume:79 Page:871-882
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Tanaka Yuki,Kume Shinji,Araki Shin-ichi,Isshiki Keiji,Chin-Kanasaki Masami,Sakaguchi Masayoshi,Sugimoto Toshiro,Koya Daisuke,Haneda Masakazu,Kashiwagi Atsunori,Maegawa Hiroshi,Uzu Takashi

Publisher

Elsevier BV

Subject

Nephrology

Reference35 articles.

1. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization;Go;N Engl J Med,2004

2. Cellular lipid metabolism and the role of lipids in progressive renal disease;Abrass;Am J Nephrol,2004

3. Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease?;Bagby;J Am Soc Nephrol,2004

4. Lipotoxicity: when tissues overeat;Schaffer;Curr Opin Lipidol,2003

5. Diseases of liporegulation: new perspective on obesity and related disorders;Unger;FASEB J,2001

Cited by 154 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fenofibrato atenua a lipotoxicidade renal em camundongos uninefrectomizados com obesidade induzida por dieta rica em gordura;Brazilian Journal of Nephrology;2024-12

2. Fenofibrate attenuates renal lipotoxicity in uninephrectomized mice with high-fat diet-induced obesity;Brazilian Journal of Nephrology;2024-12

3. Astragaloside IV attenuates fatty acid-induced renal tubular injury in diabetic kidney disease by inhibiting fatty acid transport protein-2;Phytomedicine;2024-11

4. Identifying biochemical changes in the kidney using proton nuclear magnetic resonance in an adenine diet chronic kidney disease mouse model;NMR in Biomedicine;2024-09-04

5. PPAR-α Insufficiency Enhances Doxorubicin-Induced Nephropathy in PPAR-α Knockout Mice and a Murine Podocyte Cell Line;Cells;2024-08-28